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Introduction: Celiac artery compression syndrome (CACS) can be treated successfully by division of the median arcuate
ligament and celiac plexus fibers. The standard technique is the open approach by an upper midline or left subcostal
incision. Only six single cases in which a laparoscopic transabdominal approach for CACS was used have been reported.
We prospectively evaluated the feasibility of the endoscopic retroperitoneal approach for treatment of CACS.
Methods: All patients with symptoms suggestive of CACS were evaluated using splanchnic duplex ultrasound scanning,
gastric exercise tonometry (GET), and multiplane selective splanchnic angiography. The criteria for treatment were
chronic abdominal symptoms, respiratory-dependent CA stenosis, and abnormal GET result. The release was performed
by a retroperitoneal endoscopic approach. Anatomic success of the procedure was confirmed by angiography.
Results: The endoscopic retroperitoneal approach was used to treat 46 patients with CACS. One patient (2%) required
conversion to an open procedure due to suprarenal artery bleeding. Release was ended prematurely in one patient due to
a pneumothorax resulting in loss of working space. A postoperative pneumothorax developed in two patients, of which
one needed treatment. No other complications were observed. Postoperative angiography during inspiration and
expiration showed normal vessel anatomy in 36 of 46 patients. Six of 10 patients with persisting intraluminal stenoses
were treated endovascularly. Five of these were successful, which brings the primary-assisted anatomic patency for the
total group to 89% (41 of 46 patients). Three patients are being observed, and endovascular treatment remains an option
in case of insufficient improvement. On median follow-up of 20 months (range, 2-42 months) 41 patients were free of
symptoms or showed significant improvement.
Conclusions: The endoscopic retroperitoneal approach for the release of the CA in CACS, with additional endovascular
treatment of persistent stenosis, is feasible and effective. Short-term results were comparable with the open procedure.
(J Vasc Surg 2009;50:140-7.)For half a century, the existence of celiac artery com-
pression syndrome (CACS) was open to debate. It was
reasoned that an untreated isolated CA stenosis, with only
respiration-dependent stenosis, was not likely to result in
symptoms.1 The difficulty in showing the positive relation
between intervention and relief of symptoms was the ab-
sence of a function test of the splanchnic circulation. Gas-
tric exercise tonometry (GET) was recently validated as a
function test pointing out splanchnic ischemia. The results
of GET clearly showed that symptoms of CACS have an
ischemic origin and release of the CA is an effective treat-
ment.2
The conventional treatment of CACS consists of divi-
sion of the arcuate ligament (AL), adjacent crus of the
diaphragm, removal of the plexus coeliacus, and in case of
persisting stenoses, patching or bypassing the CA origin.3
The approach could be open transabdominal by median
laparotomy or open retroperitoneal by left subcostal inci-
sion. The success rates of these interventions on vascular
patency are excellent, but the operative trauma to the
abdominal wall and cavity is extensive.
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140Consequently, an endoscopic approach seems more
attractive. Case reports have documented a laparoscopic
approach for the treatment of CACS in six patients.4-9
Owing to the complex and interdependent anatomy of the
AL, the right and left crus of the diaphragm, the CA, and
the lower esophageal sphincter, we hypothesized that a
retroperitoneal instead of an abdominal endoscopic ap-
proach would visualize the complex local anatomy more
distinctly. On the other hand, a retroperitoneal endoscopic
approach of the CA origin could be more difficult to
perform because of the complex access and the narrow
retroperitoneal working area. To our knowledge to date, an
endoscopic retroperitoneal approach for treatment of
CACS has not been described.
In our institution, a referral hospital for gastrointestinal
ischemic disorders, endoscopic retroperitoneal division of
the AL was introduced recently as the preferred treatment
of CACS. This study describes and evaluates the feasibility
and the short-term outcome of endoscopic retroperitoneal
division of the AL, combined with endovascular dilatation
in selected cases, for treatment of CACS.
METHODS
Diagnosis and treatment. All patients had under-
gone an extensive evaluation by their referring physician to
exclude more common diseases such as cholelithiasis, gas-
tric reflux, peptic ulcer (Helicobacter pylori), pancreatitis,
and irritable bowel syndrome. Additional workup included
gastroscopy, colonoscopy, abdominal computed tomogra-
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aging, gastric emptying study, small-bowel series, and
lower gastrointestinal series. The patients with clinical sus-
picion for chronic splanchnic syndrome were evaluated
using splanchnic Doppler duplex US (DUS) scanning and
GET. Multiplane selective splanchnic digital subtraction
angiography (MSS-DSA) was performed if results of DUS
scans or GET were abnormal. After completion of the
investigations, the multidisciplinary team for gastrointesti-
nal ischemia discussed all the data. CACS was suspected in
patients with chronic abdominal symptoms not caused by
other diseases, an abnormal GET result, and a significant
eccentric compression of the CA, possibly respiration-
dependent. For each patient, a consensus diagnosis was
made and treatment advice was given. Patients with signif-
icant CA compression, a history consistent of chronic gas-
trointestinal ischemia (chronic abdominal pain related to
meals or exercise, or both, and weight loss), and an abnor-
mal GET result were advised to have treatment. We con-
sidered release of the CA by cleaving the AL as the treat-
ment of first choice.2
From February 2005 to June 2008, 46 consecutive
patients with suspected CACS were treated endoscopically
by a retroperitoneal approach. Anatomic success of the CA
release was objectified by performing a DSA in the early
postoperative period in all cases. In patients with persistent
stenoses after endoscopic CA release, percutaneous trans-
luminal angioplasty (PTA) was performed with a 6-mm
balloon, and in case of rebound, with placement of an
additional stent. If located in the origin of the CA, a
balloon-expandable 6-  17-mm Express stent (Boston
Scientific, Natick, Mass), which can be placed more pre-
cisely, was used. If the stenosis was further away from the
origin, a 6-  24-mm self-expandable Wallstent RP stent
(Boston Scientific) was placed.
Duplex ultrasound. Transabdominal DUS scanning
of the CA and the superior mesenteric artery was performed
before and every 6 months after the CA release using a
standardized protocol, after 6 hours of fasting in the diag-
nostic phase and during follow-up. DUS scanning was
performed during expiration and inspiration by using 3.5-
to 5.0-MHz probes with steerable linear array or convex
sector probes. The assessment of the splanchnic artery
inflow was based on the B-mode and the peak systolic
velocity (PSV) according to criteria published byMoneta et
al.10 A PSV 200 cm/s, no flow, or retrograde common
hepatic artery flow in inspiration or expiration, or both,
were considered as a possible significant (70%) stenosis of
the CA.
Gastric exercise tonometry. GET was performed in
the diagnostic phase using a standardized protocol before,
during, and after 10 minutes of submaximal exercise, as
described previously.11 GET is based on the constant rela-
tion between increased carbon dioxide (CO2) in the mu-
cosa and lumen of the ischemic stomach or bowel. The
gastric CO2 level is measured after a 10-minute bicycle test
and compared with systemic arterial CO2 level. GET was
performed with suppression of gastric acid secretion using ahigh-dose proton pump inhibitor (PPI). The criteria for a
positive test result indicating ischemia were a gradient of
0.8 kPa after exercise, an increase in gastric PCO2, and an
arterial lactate level of 8 mmol/L.12 GET allows a diag-
nosis of gastrointestinal ischemia with a sensitivity of 78%
and a specificity of 92%.13
Twenty-four hour tonometry. Prolonged gastroin-
testinal tonometry was also performed with suppression of
gastric acid secretion using high-dose PPI, as described
previously.13 The same technique is used as in GET; how-
ever, this test is performed for 24 hours to detect gastric and
jejunal tonometry ischemia after standard meals.
For the stomach, the cutoff values were 12.1, 11.4, and
11.3 kPa for the breakfast (or bread meal), dinner, and
compound solution meals, respectively; in the jejunum,
these threshold values were 12.0, 13.6, and 10.6 kPa,
respectively. The criteria for a positive finding (abnormal
result) on 24-hour tonometry were pathologic responses
after three or more standard meals, or a combination of one
or two pathologic responses after standard meals combined
with a median PCO2 8.0 kPa measured between meals.
The sensitivity and specificity of the 24-hour tonometry
measurement for diagnosis of gastrointestinal ischemia was
76% and 94%.14,15
Angiography. MSS-DSA by an intra-arterial Seldinger
technique consisted of anterior–posterior and lateral ab-
dominal aortic injections in expiration and inspiration to
visualize the origin of the splanchnic vessels. Thereafter,
selective injections of the CA, the superior mesenteric
artery, and the inferior mesenteric artery were performed. A
significant stenoses was defined as70% luminal reduction.
A distinction was made between intraluminal stenoses and
extraluminal compression of the CA. The former is charac-
terized by concentric stenoses independent of the respira-
tory cycle; the latter is typically eccentric and varies mostly
with the respiratory cycle. Two independent investigators
(A. B. H. and R. H. G.) reviewed all MSS-DSA results. In
case of discrepancy, the MSS-DSA result was re-evaluated
by both investigators, and a definitive consensus was rea-
ched.
Operative technique. All procedures were performed
with the patient under general anesthesia by one vascular
surgeon (R. H. G.). Patient positioning and trocar place-
ment are shown in Fig. Landmarks were anterior and
posterior axillary line, iliac crest, and lower rib margin. The
patient was placed in the standard flank position, on the
right side. A vacuum mattress covered with a gelatin pad
was used. Silicon protheses were placed at knee and ankle
level to prevent decubitus or peroneal nerve damage. The
table was flexed (45°), and the kidney bridge was elevated
to flatten the lumbar region.
The open technique described by Gaur et al16 was used
to introduce a dissection balloon through a 2-cm subcostal
muscle-splitting incision close to the 11th costal space at
the midaxillary line. Before balloon introduction, the inci-
sion was deepened by finger dissection directed cranially
and dorsal of the left kidney lower pole. The balloon
catheter (Extra View, Autosuture, United States Surgical,
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into the retroperitoneal space under manual and visual
control. Under endoscopic vision, the peritoneum was
separated from the retroperitoneal cavity by inflating the
balloon catheter. Landmarks such as the psoas muscle, the
left kidney, the shoved-away dorsal and ventral peritoneal
fold, and the diaphragm were visible, ensuring the proper
space was dissected.
The balloon dilator was replaced for a 10-mm blunt-tip
trocar (Autosuture) as the primary port. Carbon dioxide
was insufflated with a pressure of 10 to 12 mmHg. A 0° or
30° endoscope was inserted, and the retroperitoneal space
was inspected. Two disposable 12-mmworking trocar (En-
dopath, Ethicon Endo-Surgery, Inc., Cincinnati, Ohio)
ports were introduced under direct vision; one trocar was
subcostal and one was close to the ventral peritoneal fold,
both in the dorsal axillary line. After further dissection of
the ventral peritoneal fold, one or two additional 12-mm
trocars were introduced in the ventral axillary line. These
trocars were used to insert two endoscopic hands (Endo
Retract II, Autosuture). One trocar was used to move the
peritoneal sac with the spleen to the right, and an optional
second trocar was used to retract the kidney and suprarenal
gland caudally.
Blunt dissection was continued to enlarge the retroper-
itoneal space. The peritoneum was dissected from the dia-
phragm downwards until the upper pole of the kidney was
visualized. The back part of the peritoneum was dissected
from the adrenal gland and kidney in the medial direction.
By using the spine as a landmark, the suprarenal aorta could
be easily found surrounded by the left crus of the dia-
phragm. The CA origin was found clearing the aorta by
dissecting the crus and AL tissue in a left anterior plane
downward from the crus. When the CA was identified, the
left crus was further incised and the left branches of the
celiac plexus were dissected to obtain complete release of
the first 5- to 20-mm of the CA. Precautions to recognize
the left suprarenal artery in a timely manner are mandatory
to prevent significant bleeding. A drain was left in the
Fig. Patient positioning and trocar placement.retroperitoneal space through one of the 12-mm trocars.Follow-up. MSS-DSA was performed before dis-
charge. Patients were scheduled for follow-up at 3 and 6
months and yearly thereafter for assessment of clinical
and anatomic status by DUS imaging. Symptoms were
scored as free of symptoms, improvement, or persistent
symptoms.
Statistical analysis. Data were expressed as mean
(standard error of mean) with range, when appropriate.
Differences betweenmeans of variables were determined by
the two-tailed t test for paired data. Values of P .05 were
considered significant.
RESULTS
From February 2005 to June 2008, 363 consecutive
patients were screened for chronic splanchnic ischemia. A
stenosis of one or more of the splanchnic arteries (celiac,
superior and inferior mesenteric) was found in 132 pa-
tients. This heterogenous group comprised patients with
one-, two- or three-vessel (atherosclerotic/intraluminal
stenosis) splanchnic disease and those with CACS (extralu-
minal stenosis). Of these 132 patients, 46 (38women) were
diagnosed with CACS and were included in this study.
Eighty percent of these patients were referred to our hos-
pital from outside the region.
Typical symptoms present in all patients consisted of
postprandial complaints such as pain, nausea, or bloating or
brick feeling in the stomach occurring 15 minutes to 1 to 2
hours after a meal. Pain was provoked by bending forward
in 48% or by exercise in 72%, and 32% of patients presented
with urge to defecate or with diarrhea related to eating.
Most patients had made accommodations for this in daily
life by eating small portions of easily digestible food more
frequently.
Physical examination found abdominal bruit in 10 of
46 patients (26%) and weight loss in 34 (74%). Patient
characteristics and preoperative investigations are summa-
rized in Table I and postoperative details in Table II. Mean
data include age, 38 years (range 16-76 years); body mass
index, 22 kg/m2 (range 14-36 kg/m2); and duration of
abdominal symptoms, 21 months (range 3-96 months).
The preoperative inspiratory CA-PSV was 274  17 cm/s
(range 75-595 cm/s), and the expiratory CA-PSV was 381
22 cm/s (range, 109-640 cm/s; P  .0005).
Seven patients had no flow on DUS imaging during
expiration, corresponding with complete occlusion of the
CA. MSS-DSA in 36 of the 46 patients showed a CA
stenosis that increased only during expiration, and in four
patients, the increase was exclusively during inspiration. Six
patients had a near-occlusion of the CA during inspiration
and expiration due to an excentric compression but lacked
clear influence caused by respiration. In one patient a
discrepancy was noted between the DUS and MSS-DSA
studies, and a MSS-DSA was performed based on the
typical complaints and positive tonometry results. A preop-
erative GET could not be performed in one patient. All but
one of the remaining 45 patients had an abnormal preop-
erative GET result or 24-hour tonometry, or both. In the
mentioned patients without GET and normal GET, the
e sele
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treatment. The patients were informed of these findings
and a consequently lower chance of success. Both patients,
one after additional endovascular therapy, were free of
symptoms after treatment.
The mean operative procedure time was 130 7 min-
utes (range, 72-272 minutes), with a clear learning curve.
The first 10 patients had a significantly longer operating
time of 178  52 minutes compared with 102  45
Table I. Preoperative patient characteristics and clinical pr
Patient
Demographics
Abdominal symptoms Duple
Sex Age BMI
Weight
loss Duration Meal Exercise
PSV
In
1 F 31 25 Yes 6 Yes Yes 19
2 F 61 32 No 12 Yes Yes 24
3 F 19 19 Yes 12 Yes Yes 30
4 F 68 36 No 18 Yes Yes
5 F 26 17 Yes 12 Yes Yes 41
6 F 47 21 Yes 4 Yes Yes 21
7 F 50 19 Yes 6 Yes No 21
8 F 50 18 Yes 9 Yes Yes 28
9 M 67 22 Yes 18 Yes No 19
10 F 20 21 No 12 Yes No 39
11 F 43 24 Yes 33 Yes Yes 27
12 F 18 20 No 57 Yes Yes 34
13 F 59 19 Yes 21 Yes Yes 7
14 F 25 26 Yes 4 Yes Yes 14
15 F 36 24 Yes 56 Yes Yes 33
16 F 55 19 Yes 4 Yes No
17 F 47 24 No 96 Yes Yes 14
18 M 42 22 Yes 22 Yes Yes 14
19 M 23 19 No 5 Yes Yes 25
20 F 19 20 No 36 Yes Yes 16
21 F 20 14 Yes 12 Yes Yes 44
22 F 30 20 Yes 12 Yes No 36
23 M 41 24 Yes 36 Yes Yes 26
24 F 37 33 No 6 Yes Yes —
25 F 22 18 Yes 4 Yes Yes 28
26 F 20 20 Yes 11 Yes Yes 29
27 F 38 16 Yes 48 Yes Yes 12
28 F 62 21 Yes 9 Yes No 29
29 F 16 18 Yes 4 Yes Yes 37
30 F 26 22 Yes 24 Yes Yes 23
31 F 28 22 No 7 Yes Yes 59
32 F 16 16 Yes 66 Yes Yes 23
33 F 59 22 Yes 36 Yes Yes 39
34 F 25 20 Yes 7 Yes Yes 27
35 F 42 16 Yes 22 Yes Yes 21
36 M 26 29 Yes 33 Yes No
37 F 48 18 Yes 14 Yes No 23
38 M 76 23 Yes 24 Yes Yes 43
39 F 18 19 Yes 6 Yes No 13
40 F 31 34 No 10 Yes No 15
41 F 43 21 No 32 Yes Yes 34
42 F 47 21 Yes 3 Yes No 45
43 M 44 30 No 36 Yes Yes ...
44 F 22 21 Yes 48 Yes Yes 28
45 F 33 30 Yes 7 Yes No 16
46 M 74 22 Yes 5 Yes No 28
BMI, Body mass index;GET, gastric exercise tonometry;MSS-SSA,multiplanminutes for the last 10 patients (P  .005). Complicationsoccurred in four patients. In patient 4, the procedure was
converted because of bleeding of the left suprarenal artery
nearly at the end of the successful AL division. In patient
14, the endoscopic procedure was ended before the AL
division was completed because the parietal left pleural fold
was accidently cut at the level of the left crus and a pneu-
mothorax developed. This resulted in loss off retroperito-
neal working space. Conversion to an open procedure was
not performed according to the preoperative agreement
tation
Preoperative data
MSS-DSA GET
V
x In, % Ex, % Gastric Jejunal 24-h T gastric/jejunal
9 5-15 70-98 Abnormal Normal Normal/Normal
8 70-98 50-69 Normal Abnormal Normal/Abnormal
2 0 70-98 Normal Normal Abnormal/Normal
6 0 70-98 Abnormal Normal Abnormal/Abnormal
4 0 70-98 Normal Abnormal Normal/Abnormal
3 50-69 70-98 Abnormal Abnormal Normal/Normal
1 5-15 70-98 Normal Normal Abnormal/Normal
3 16-49 70-98 Abnormal ... Abnormal/Normal
5 5-15 50-69 Abnormal Abnormal Normal/Normal
5 0 70-98 Abnormal Abnormal Abnormal/Normal
0 50-69 70-98 Abnormal Abnormal Normal/Normal
0 70-98 70-98 Abnormal Abnormal Normal/Normal
9 70-98 0 Abnormal Abnormal Normal/Normal
0 0 70-98 Abnormal Normal Normal/Normal
0 0 70-98 Abnormal Abnormal Normal/Normal
0 0 70-98 Abnormal Normal Normal/Abnormal
0 0 70-98 Normal Abnormal Abnormal/Normal
0 0 70-98 Normal Normal Normal/Abnormal
1 16-49 70-98 Normal Abnormal Normal/Normal
4 0 50-69 Abnormal Normal Normal/Normal
0 5-15 70-98 Abnormal Abnormal Abnormal/Normal
4 0 50-69 ... ... Normal/...
1 0 70-98 Normal Normal Normal/Abnormal
2 16-49 70-98 Abnormal Normal Abnormal/Normal
1 0 50-69 Abnormal Abnormal Normal/Normal
9 0 99 Abnormal Abnormal Normal/Normal
7 0 50-69 Abnormal ... Normal/...-
9 occl 50-69 Abnormal Abnormal Abnormal/Normal
0 99 99 Normal Abnormal Abnormal/Normal
0 0 70-98 Abnormal Abnormal Normal/Normal
8 70-98 70-98 Normal Normal Normal/Normal
8 70-98 70-98 Abnormal Normal Abnormal/Normal
0 70-98 99 Abnormal Normal Normal/Abnormal
1 70-98 0 Abnormal Abnormal Normal/Abnormal
6 0 70-98 Normal Normal Abnormal/Normal
0 0 70-98 Normal Abnormal Abnormal/Abnormal
2 0 70-98 ... ... Normal/Abnormal
5 70-98 70-98 Abnormal Normal Normal/Abnormal
4 70-98 0 Normal Abnormal Normal/Normal
0 50-69 70-98 Abnormal Normal Abnormal/Normal
2 0 70-98 Normal Abnormal Normal/Abnormal
7 16-49 70-98 Normal Abnormal .../...
. 0 70-98 Abnormal Abnormal Normal/Normal
7 0 70-98 Abnormal Abnormal Normal/Normal
7 0 70-98 Abnormal Normal Normal/Normal
7 0 70-98 Abnormal Abnormal Abnormal/Abnormal
ctive splanchnic digital subtraction angiography; PSV, peak systolic velocity.esen
x
PS
E
4 21
9 25
8 29
0 30
2 39
6 36
8 43
6 35
2 44
8 39
0
1 46
5 10
5 64
5 39
0
7 44
0
6 43
6 29
2 33
8 42
7 43
26
1 44
0 48
2 25
1 11
4
7 64
5 62
7 32
2 60
0 12
6 41
0
8 34
4 32
7 39
5
8 45
3 61
..
7 37
9 27
7 37with the patient. Postoperative pneumothorax developed
ne sel
s.
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other complications occurred.
Postoperative angiography was performed in all pa-
tients but two, who were free of symptoms or showed
significant improvement of symptoms and the DUS study
was normalized. The postoperative angiography showed
normal CA anatomy in 31 of 44 patients, and minor
persisting tailoring was evident in three patients for a pri-
Table II. Postoperative patient characteristics and clinical
Patient
Abdominal
symptoms Duplex MSS-DSA, %
Meal Exercise PSV In PSV ex In Ex
1 No No 180 164 0 0
2 Yes Yes 243 254 0 0
3 Yes Yes 338 366 0 0
4 No No 156 206 0 0
5 No No 217 211 0 0
6 No No 150 159 0 0
7 Yes No 215 172 0 5-15
8 No No 249 167 0 0
9 Yes No 142 280 ... ...
10 No No 286 345 ... ...
11 No No 177 217 50-69 70-98
12 No No 420 — 70-98 70-98
13 Yes Yes 85 82 0 5-15
14 Yes Yes ... ... 0 50-69
15 Yes No 165 132 0 0
16 No No 171 202 0 0
17 Yes Yes 214 290 0 0
18 No No 164 134 0 0
19 No No 153 160 0 0
20 No No 93 173 0 0
21 Yes No 150 147 5-15 70-98
22 No No 367 447 0 5-15
23 No No 131 152 0 0
24 Yes No ... ... 5-15 5-15
25 No No 120 259 0 0
26 No No 392 473 0 50-69
27 Yes No 112 218 0 16-49
28 No No 217 156 0 0
29 Yes Yes 213 233 0 0
30 No No 240 179 0 0
31 No No 201 189 70-98 70-98
32 No No 181 209 0 0
33 No No 156 154 0 0
34 No No 90 99 0 0
35 No No 181 144 0 0
36 Yes No 374 449 0 16-49
37 No No 202 191 0 0
38 Yes No 270 258 70-98 16-49
39 No No 176 258 0 0
40 Yes No 198 238 50-69 70-98
41 No No 178 190 0 16-49
42 Yes No 467 366 16-49 70-98
43 No No ... ... 0 0
44 No No 291 223 0 0
45 No No 254 266 0 0
46 No No 291 223 0 0
Conv, Conversion; FU, follow-up; Hosp, hospitalization; MSS-SSA, multipla
aImprovement: 1, free of symptoms; 2, improvement; 3, persistent symptommary anatomic patency of 78% (36 of 46 patients).Ten patients showed reduced but persisting significant
intraluminal CA stenoses. Endovascular treatment was per-
formed, depending on the grade of persisting stenosis and
symptoms. PTA was used to treat six of these patients,
including stent placement in three patients. These addi-
tional endovascular treatments were successful in five pa-
tients. In one of these six patients, an attempt to place a
stent by the femoral approach did not succeed. Access of
entation
operative
mplication Endovasc Impra
Hosp OT FU
(days) (min) (mon)
1 4 240 42
3 4 113 42
2 4 154 42
v/bleeding 1 10 272 41
1 5 220 38
1 4 157 38
2 6 179 38
1 5 149 37
2 5 171 36
1 4 120 35
PTA/stent 1 8 149 33
PTA 1 6 153 33
2 6 87 33
umothorax 3 21 142 30
2 4 143 29
1 14 100 27
3 5 114 26
1 4 100 26
1 5 182 25
1 5 94 24
PTA/stent 2 11 87 23
1 5 131 21
1 5 115 23
2 6 113 19
1 3 96 17
PTA 1 6 192 17
PTA attempt 2 4 85 16
1 5 85 16
3 4 130 16
1 4 112 14
PTA/stent 1 4 72 14
1 5 119 13
1 5 147 12
umothorax 1 8 159 11
umothorax 1 5 78 9
2 5 92 7
1 5 96 7
2 4 74 6
1 4 97 6
3 3 90 6
1 3 81 6
2 4 145 6
1 3 123 6
1 5 129 4
1 5 155 4
1 8 129 2
ective splanchnic digital subtraction angiography; OT, operating time.pres
Post
Co
Con
Pne
Pne
Pnethe brachial artery was not performed after the higher
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were taken into account. Symptoms were slightly improved
in three patients with persisting CA stenoses, and they were
followed up conservatively. Endovascular treatment re-
mains an option in these patients according to clinical
symptoms. These last three patients together with the
patient who did not undergo additional stent placement
through the brachial access and the patient with iatrogenic
pneumothorax and consequently interrupted release results
in a total of five patients who did not have an anatomically
successful release. As a consequence, the primary-assisted
anatomic patency for the total group is 89% (41 of 46
patients).
Of the 46 patients (65%), 30 were free of symptoms,
including four patients with additional endovascular proce-
dure, and 11 reported clear improvement of symptoms,
including one patient with an additional endovascular pro-
cedure. Five patients, including the patient with the proce-
dure that ended prematurely, noticed no positive influence
on their symptoms. The primary clinical success was 78%
(36 of 46 patients). The primary-assisted clinical success of
this procedure was 89% (41 of 46 patients). The mean
hospital stay was 5.6 days (range, 3-21 days). The median
follow-up was 20 months (range 2-42 months).
Normal anatomy together with free or significant im-
provement of symptoms was found in 38 patients (83%).
Three patients had symptoms despite normalized anatomy,
and three were free of symptoms despite persistent stenosis.
One patient with persisting symptoms and an incomplete
release underwent an additional open transabdominal CA
release. Most of the CA, the common hepatic artery, and
the splenic artery were incorporated in the pancreas, which
was a clear explanation of the difficulties experienced by the
attempt of endoscopic AC release. On follow-up, postop-
erative DUS imaging (PSV of 216  14 cm/s during
inspiration and 224  14 cm/s during expiration) was
normalized compared with preoperative results (P .001),
and respiratory-dependent differences disappeared.
DISCUSSION
The present study of a retroperitoneal endoscopic ap-
proach for release of the CA indicates that this technique is
a safe, feasible, and effective treatment of CACS. Our study
is distinguished from previous reports because it included
preoperative GET to support the CACS diagnosis2 and
postoperative MSS-DSA in inspiration and expiration to
record successful CA release. Consequently, endoscopic
retroperitoneal CA release, combined in selected patients
with an additional endovascular procedure, is the preferred
treatment of patients with CACS.
The mere existence of CACS has been debated. Au-
topsy and angiographic studies have showed an incidence
of splanchnic artery stenoses of 20% to 70%.1,17-19 The
main arguments against the existence of symptomatic CA
compression included the high frequency of asymptomatic
isolated CA compression20 and the idea that the existence
of the rich splanchnic collateral circulation prevents
splanchnic ischemia in case of one-vessel disease.Moreover,several studies suggested that durable relief of symptoms
after surgery is rare.17-19,21 Proponents argued that durable
effects of surgery in selected patients were reported.3,22-30
We believe that GET plays an important role in this
selection.2,12 We reported that an extensive preoperative
work-up that included GET could result in durable relief of
symptoms after classic CA release by an open subcostal
approach in 80% of patients.2 Twenty-four hour tonometry
could possibly be supplementary.14 We are now analyzing a
study comparing GET and 24-hour tonometry. The pre-
liminary data suggest that 24-hour tonometry permits ac-
curate measurement of postprandial and fasting PCO2.
In the present study, which included endoscopic CA
release, we found a primary-assisted clinical success of 89%.
Postoperative GET was not performed because our previ-
ous study showed normalization of tonometry after CA
release in patients with CACS.2 In this study, the results on
repeated tonometry after open repair improved in the 16
patients (100%) who were free of symptoms and in one of
the four patients (25%) with persistent complaints (P 
.0008). This supports our present opinion that, with GET
also included, it is still not possible to perfectly distinguish
nonsymptomatic from symptomatic CA stenoses.
It has been suggested that the abdominal symptoms in
CACS patients could be neurogenic, originating from com-
pression of the periarterial neural tissue of the celiac ple-
xus.31-33 Surgical treatment with removal of the plexus
might have been considered a “neurolytic procedure.” The
current study strongly contradicts this notion. In our en-
doscopic approach, only the left crus is divided, including
adjacent plexus fibers, which keeps the plexus intact for the
most part. Moreover, we have previously shown that reso-
lution of symptoms was strongly associated with restoration
of blood flow and disappearance of ischemia on postoper-
ative tonometry.2 Therefore, we no longer believe that the
celiac plexus has to be removed completely. Another ad-
vantage is that this minimal approach minimizes the occur-
rence of gastroesophageal reflux disease (GERD) caused by
damage to the lower esophageal sphincter. We found an
incidence 9% of GERD after open CACS release,2 and none
of the patients in our series experienced this complication.
The transabdominal laparoscopic approach of the ret-
roperitoneum was described much earlier by Jacobeus34
than the (gasless) retroperitoneoscopy by Bartel et al.35
The introduction of the balloon dissector by Gaur et al16 in
1992 for dissection of the retroperitoneumwithout the risk
of injuring other structures was a major step forward. The
first experience with laparoscopic aortic surgery was in
1993 when Dion et al36 performed the first laparoscopy-
assisted aortobifemoral bypass. Thereafter, two different
approaches of the aorta have evolved: the transperitoneal
and retroperitoneal approach. Both approaches have their
own advantages and difficulties.37 Roayaie et al4 were the
first to describe a transperitoneal approach for celiac release
within a single case, followed by some case reports.5-8
In our experience, the retroperitoneal approach pro-
duced an excellent exposure of the CA and crus in nearly all
patients. Advantages compared with the open technique
JOURNAL OF VASCULAR SURGERY
July 2009146 van Petersen et alare clear—less operative trauma and decreased longstand-
ing abdominal wall pain—resulting in a shorter mean hos-
pital stay of 5.6 days compared with 8.6 days for patients
who underwent an open procedure.2 Length of stay in the
present study is still quite long for an endoscopic proce-
dure. This can be attributed to a cautious resumption of
oral intake. In our experience, a normal diet is not well
tolerated immediately after CA release in most patients.
Roayaie and Carbonell4,6 recommend perioperative as-
sessment of the artery by endoscopic DUS imaging after
decompression.We do not have the facilities tomonitor the
release by perioperative endoscopic DUS imaging. The
added value of this technique perioperatively is arguable
because general anesthesia with muscle relaxation makes
it impossible to determine respiration-dependent flow
changes. This was the main reason we applied MSS-DSA,
including endovascular treatment of persisting stenoses, if
appropriate 1 or 2 days after the endoscopic CA-release.
This resulted in a primary-assisted anatomic and clinical
success of 89%, without relevant adverse side effects.
In the patients who underwent intraluminal CA stent
placement, the persisting stenoses were resolved with very
little balloon pressure. A small persisting part of the AL or
fibrous tissue, which can easily be disrupted by PTA, could
be the cause of the persisting stenosis. Preparing the CA so
that it is completely bare could increase the chance of
damaging of the fragile CA wall and result in severe bleed-
ing as a consequence. It is very important to realize that
stenting should only be performed if the AL is properly
divided. Stenting with an intact AL leads to kinking or
wrecking of the stent.38
A careful evaluation of the operative procedure in the
last three patients with a persisting stenosis showed that the
CA release may be of insufficient length in an attempt to
minimize the surgical trauma to the lower esophageal
sphincter and to decrease the chance of vascular trauma. It
is important to remember that a nearby complete release of
the CA seems to be crucial for success.
The present study, which included patients with
chronic abdominal symptoms, abnormal GET results, and a
respiration-dependent significant compression of the CA,
showed the feasibility and efficacy of endoscopic retroper-
itoneal CA release in combination with endovascular treat-
ment of persisting intraluminal CA stenoses.
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